Clinical Trials Directory

Trials / Completed

CompletedNCT06334926

BMI and Lymph Node Count in Colorectal Cancer

Prediction of Survival in Colorectal Cancer Patients on the Basis of Body Mass Index and Lymph Node Yield - a Retrospective Single Center Cohort Analysis Over a Quarter of a Century

Status
Completed
Phase
Study type
Observational
Enrollment
1,192 (actual)
Sponsor
Klinikum Floridsdorf · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Background and aim: Colorectal Cancer (CRC) is one of the most frequent cancer entities in the western world. It is known that obesity is one of the major risk factors for CRC. In contrast, mild obesity seems to have a positive effect on postoperative outcome, which is known as the "obesity paradox". Also, the number of resected lymph nodes (LN) during surgery is very important for correct staging. The aim of the present project is to evaluate the impact of BMI and LN-yield on long term overall survival (OS) of CRC patients treated with curative intent. Methods: Patients treated for CRC between 1998 and 2011 at the Klinik Favoriten in Vienna, Austria were analyzed in this retrospective single-center cohort analysis concerning OS.

Conditions

Interventions

TypeNameDescription
OTHERno intervention, retrospective data analysisnot applicable, retrospective data analysis

Timeline

Start date
2017-12-01
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2024-03-28
Last updated
2024-03-28

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT06334926. Inclusion in this directory is not an endorsement.